Skip to content
Le Territoire Médical
Create an account

WHO Model List

linezolid

International nonproprietary name (English: linezolid). Brand names vary by country.

Indications retained by WHO

Multi-drug resistant Mycobacterium tuberculosis; Other specified bacterial diseases, Vancomycin resistant Enterococcus, Vancomycin resistant Staphylococcus aureus, Methicillin resistant Staphylococcus aureus (complementary list).

Listed forms and strengths

  • Parenteral > General injections > IV: 2 mg per mL in 300 mL bag
  • Oral > Liquid: 100 mg per 5 mL powder for oral liquid
  • Oral > Solid: 600 mg tablet; 400 mg tablet
  • Oral > Solid > dispersible tablet: 150 mg (scored)
  • Oral > Solid > tablet: 600 mg
  • Oral > Solid > dispersible tablet: 150 mg

Forms retained in the model list; presentations available in each country may differ.

General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.

Source: WHO electronic Essential Medicines List (2025 edition), checked on 14/11/2026. An error or an imprecision? Let us know